FRANCOLINI, GIULIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.915
EU - Europa 3.708
AS - Asia 3.508
SA - Sud America 363
Continente sconosciuto - Info sul continente non disponibili 104
AF - Africa 72
OC - Oceania 42
AN - Antartide 1
Totale 14.713
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.750
RU - Federazione Russa 1.399
SG - Singapore 1.020
CN - Cina 975
IT - Italia 885
HK - Hong Kong 501
KR - Corea 297
PL - Polonia 291
BR - Brasile 279
VN - Vietnam 262
IE - Irlanda 244
DE - Germania 183
SE - Svezia 183
FR - Francia 182
GB - Regno Unito 104
FI - Finlandia 102
CA - Canada 101
IN - India 95
BD - Bangladesh 81
JO - Giordania 81
ID - Indonesia 42
AU - Australia 40
JP - Giappone 33
AR - Argentina 32
NL - Olanda 28
IQ - Iraq 25
MX - Messico 22
ES - Italia 21
EC - Ecuador 17
TR - Turchia 17
ZA - Sudafrica 15
BE - Belgio 13
CH - Svizzera 12
VE - Venezuela 12
CI - Costa d'Avorio 11
CZ - Repubblica Ceca 11
UA - Ucraina 11
NG - Nigeria 10
LT - Lituania 9
SA - Arabia Saudita 9
CR - Costa Rica 8
PK - Pakistan 8
TN - Tunisia 8
UZ - Uzbekistan 8
AE - Emirati Arabi Uniti 7
CO - Colombia 7
EG - Egitto 7
JM - Giamaica 7
MA - Marocco 7
CL - Cile 6
KE - Kenya 6
KZ - Kazakistan 6
PH - Filippine 6
TT - Trinidad e Tobago 6
IL - Israele 5
BH - Bahrain 4
HN - Honduras 4
MY - Malesia 4
UY - Uruguay 4
AT - Austria 3
BJ - Benin 3
BY - Bielorussia 3
DO - Repubblica Dominicana 3
GR - Grecia 3
GT - Guatemala 3
KG - Kirghizistan 3
LB - Libano 3
PE - Perù 3
AL - Albania 2
BB - Barbados 2
BG - Bulgaria 2
DK - Danimarca 2
DZ - Algeria 2
EE - Estonia 2
HU - Ungheria 2
KH - Cambogia 2
LK - Sri Lanka 2
LV - Lettonia 2
NP - Nepal 2
NZ - Nuova Zelanda 2
PA - Panama 2
PR - Porto Rico 2
PT - Portogallo 2
PY - Paraguay 2
RO - Romania 2
SK - Slovacchia (Repubblica Slovacca) 2
AO - Angola 1
AQ - Antartide 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BM - Bermuda 1
CG - Congo 1
DM - Dominica 1
EU - Europa 1
GE - Georgia 1
IR - Iran 1
LA - Repubblica Popolare Democratica del Laos 1
NI - Nicaragua 1
OM - Oman 1
PS - Palestinian Territory 1
Totale 14.600
Salva come PNG Salva come JPEG
Città #
Santa Clara 1.282
Ashburn 951
Singapore 755
Hong Kong 442
Fairfield 391
San Jose 345
Seoul 296
Chandler 291
Warsaw 280
Hefei 277
Dublin 242
Woodbridge 206
Seattle 199
Houston 160
Cambridge 150
Beijing 144
Wilmington 143
Milan 137
Los Angeles 130
Munich 111
Council Bluffs 103
Buffalo 97
Ann Arbor 87
Ho Chi Minh City 83
Rome 83
New York 80
Florence 78
Dearborn 77
Paris 75
Lauterbourg 67
Lawrence 66
Moscow 66
Altamura 65
Chicago 65
The Dalles 63
Hanoi 53
Princeton 53
Kent 51
Shanghai 50
Helsinki 48
Phoenix 42
Boston 39
São Paulo 39
Melbourne 34
San Diego 32
Mumbai 31
Turku 30
Frankfurt am Main 29
Brooklyn 28
London 28
Medford 27
Clifton 26
Dallas 26
Jakarta 24
Naples 24
Toronto 24
Tokyo 23
Orem 22
Montreal 20
San Francisco 20
Bengaluru 16
Stockholm 16
Boardman 14
Bologna 14
Chennai 14
Guangzhou 14
Turin 14
Baghdad 13
Brussels 13
Genoa 13
Lappeenranta 13
Shenzhen 12
Abidjan 11
Atlanta 11
Figino 11
West Jordan 11
Bari 10
Brescia 10
Da Nang 10
Denver 10
Dong Ket 10
Haiphong 10
Pune 10
Salt Lake City 10
Abuja 9
Belo Horizonte 9
Johannesburg 9
Amsterdam 8
Cascina 8
Elk Grove Village 8
Falls Church 8
Manchester 8
Miano 8
Padua 8
Poplar 8
Tashkent 8
Venice 8
Yubileyny 8
Brasília 7
Mexico City 7
Totale 9.329
Salva come PNG Salva come JPEG
Nome #
Use of an alpha lipoic, methylsulfonylmethane and bromelain dietary supplement (Opera®) for chemotherapy-induced peripheral neuropathy management, a prospective study 409
Postmastectomy radiotherapy for locally advanced breast cancer receiving neoadjuvant chemotherapy. 303
Efficacy and tolerability of cyberknife stereotactic robotic radiotherapy for primary or secondary orbital lesions: A single-center retrospective experience 290
Accelerated partial breast irradiation using intensity modulated radiotherapy versus whole breast irradiation: Health-related quality of life final analysis from the Florence phase 3 trial 279
A matched cohort study of radio-chemotherapy versus radiotherapy alone in soft tissue sarcoma patients 259
Pros-IT CNR: an Italian prostate cancer monitoring project 257
Use of an alfa-lipoic, Methylsulfonylmethane, Boswellia serrata and Bromelain dietary supplement (OPERA®) for aromatase inhibitors-related arthralgia management (AIA): a prospective phase II trial (NCT04161833) 250
Role of magnetic resonance imaging in the preoperative staging and work-up of patients affected by invasive lobular carcinoma or invasive ductolobular carcinoma 250
Stereotactic reirradiation for local failure of brain metastases following previous radiosurgery: Systematic review and meta-analysis 248
Stereotactic vacuum-assisted breast biopsy: Comparison between 11- and 8-gauge needles 240
Aprepitant as prophylaxis of chemotherapy-induced nausea and vomiting in anthracyclines and cyclophosphamide-based regimen for adjuvant breast cancer 232
Accelerated partial breast irradiation using intensity-modulated radiotherapy technique compared to whole breast irradiation for patients aged 70 years or older: subgroup analysis from a randomized phase 3 trial 227
Elderly patients affected by head and neck squamous cell carcinoma unfit for standard curative treatment: Is de-intensified, hypofractionated radiotherapy a feasible strategy? 226
Triple Negative Apocrine Carcinomas as a Distinct Subtype of Triple Negative Breast Cancer: A Case-control Study 224
Influence of age and subtype in outcome of operable liposarcoma 224
Peroxisome proliferator activated receptor-gamma stimulation for prevention of 5-fluorouracil-induced oral mucositis in mice 222
Benefit of ablative versus palliative-only radiotherapy in combination with nivolumab in patients affected by metastatic kidney and lung cancer 219
Gamma Knife Radiosurgery in the management of single and multiple brain metastases 218
Phase 2 placebo-controlled, single-blind trial to evaluate the impact of oral ibandronate on bone mineral density in osteopenic breast cancer patients receiving adjuvant aromatase inhibitors: 5-year results of the single-centre BONADIUV trial 216
Methodological approach to create an atlas using a commercial auto-contouring software 212
Systemic therapies and cognitive impairment for breast cancer: an overview of the current literature 210
Enhancing patient safety in radiotherapy: Implementation of a customized electronic checklist for radiation therapists 208
Stereotactic radiotherapy in oligoprogressive and oligorecurrent urothelial cancer patients: A retrospective experience 205
BRCA mutation in breast cancer patients: Prognostic impact and implications on clinical management 205
Predictive factors for additional non-sentinel lymph node involvement in breast cancer patients with one positive sentinel node 202
Prognostic Impact of Post-Diagnosis Smoking Cessation among Bladder Cancer Patients: A Systematic Literature Review and Meta-Analysis 201
Thermal Ablation versus SBRT in liver tumours: pros and cons 201
Stereotactic body radiation therapy (SBRT) on renal cell carcinoma, an overview of technical aspects, biological rationale and current literature 200
Re-irradiation as salvage treatment in recurrent glioblastoma: A comprehensive literature review to provide practical answers to frequently asked questions 200
Impact of COVID-19 on patient–doctor interaction in a complex radiation therapy facility 199
Assessment of a guideline-based heart substructures delineation in left-sided breast cancer patients undergoing adjuvant radiotherapy: Quality assessment within a randomized phase III trial testing a cardioprotective treatment strategy (SAFE-2014) 196
Outcome and prognostic factors for older patients undergoing radiosurgery for brain metastases 196
Dosimetric Predictors of Acute and Chronic Alopecia in Primary Brain Cancer Patients Treated With Volumetric Modulated Arc Therapy 195
Safety of eribulin mesylate and concomitant radiotherapy for metastatic breast cancer: a single-center experience 193
Impact of hormonal status on outcome of ductal carcinoma in situ treated with breast-conserving surgery plus radiotherapy: Long-term experience from two large-institutional series 192
Impact of COVID-19 on workload burden of a complex radiotherapy facility 191
Stereotactic Body Radiotherapy in Oligomestatic/Oligoprogressive Sarcoma: Safety and Effectiveness Beyond Intrinsic Radiosensitivity 191
Artificial Intelligence in radiotherapy: state of the art and future directions 190
Radiosensitizing Effect of Trabectedin on Human Soft Tissue Sarcoma Cells 188
Early biochemical outcomes following PSMA guided approach for bIoCHEmical relapse after prostatectomy-PSICHE trial (NCT05022914): preliminary results 185
Incidence of skin toxicity in squamous cell carcinoma of the head and neck treated with radiotherapy and cetuximab: A systematic review 185
Stereotactic or conventional radiotherapy for macroscopic prostate bed recurrence: a propensity score analysis 181
Three Months' PSA and Toxicity from a Prospective Trial Investigating STereotactic sAlvage Radiotherapy for Macroscopic Prostate Bed Recurrence after Prostatectomy-STARR (NCT05455736) 181
Modulation of tumor-associated macrophage activity with radiation therapy: a systematic review 181
Clinical validation of an automatic atlas-based segmentation tool for male pelvis CT images 181
PSMA guided approach for bIoCHEmical relapse after prostatectomy- (PSICHE) trial (NCT05022914). Detection rate and treatment decision after 68Ga-PSMA PET/CT within a prospective study 180
Predictive factors for tolerance to taxane based chemotherapy in older adults affected by metastatic prostate cancer (ANCHISES-NCT05471427): A prospective observational trial including patients with metastatic hormone sensitive and castrate resistant prostate cancer treated with taxane chemotherapy 179
Stereotactic Re-irradiation in Recurrent Prostate Cancer after Previous Postoperative or Definitive Radiotherapy: Long-term Results after a Median Follow-up of 4 Years 177
Quality of life after definitive treatment for bladder cancer: A systematic review and meta-analysis 174
Prospective assessment of AR splice variant and multi-biomarker expression on circulating tumor cells of mCRPC patients undergoing androgen receptor targeted agents: interim analysis of PRIMERA trial (NCT04188275) 171
Study protocol and preliminary results from a mono-centric cohort within a trial testing stereotactic body radiotherapy and abiraterone (ARTO-NCT03449719) 170
Pattern of Recurrence After Stereotactic Radiotherapy in Prostate Cancer Patients With Nodal Pelvic Relapse. A Multi-Institutional Retrospective Analysis 166
Prospective assessment of AR splice variant and PSMA detection on circulating tumor cells of mCRPC patients: preliminary analysis of patients enrolled in PRIMERA trial (NCT04188275) 164
Application of Radiomics for the Prediction of Radiation-Induced Toxicity in the IMRT Era: Current State-of-the-Art 163
In reply to Egger et al.: Lack of benefit from adjuvant postoperative radiotherapy and issues raised about upfront management of high- and very-high-risk prostate cancer patients 161
Subclinical cardiac damage monitoring in breast cancer patients treated with an anthracycline-based chemotherapy receiving left-sided breast radiation therapy: subgroup analysis from a phase 3 trial 159
Anatomical assessment of local recurrence site in breast cancer patients after breast reconstruction and post-mastectomy radiotherapy: implications for radiation volumes and techniques 156
Preoperative radiotherapy: A paradigm shift in the treatment of breast cancer? A review of literature 156
Preoperative robotic radiosurgery for early breast cancer: Results of the phase II ROCK trial (NCT03520894) 155
In reply to: Anti-HER2 neoadjuvant treatment may have an impact on discordance between preoperative core needle biopsy and surgical specimen in early breast cancer 155
Prognostic impact of nodal relapse in definitive prostate-only irradiation 155
PERSIAN trial (NCT05717660): an ongoing randomized trial testing androgen deprivation therapy, apalutamide and stereotactic body radiotherapy. An alternative "triplet" for oligometastatic hormone sensitive prostate cancer patients 153
Single-fraction stereotactic body radiotherapy for oligometastatic lymph node relapse in prostate cancer 153
Integrating stereotactic body radiation therapy (SBRT) and systemic treatments in oligoprogressive prostate cancer: new evidence from the literature 151
Impact of stereotactic body radiotherapy vs palliative radiotherapy on oncologic outcomes of patients with metastatic kidney cancer concomitantly treated with immune checkpoint inhibitors: a preliminary, multicentre experience 150
Robotic stereotactic radiotherapy for liver oligometastases from colorectal cancer: a single-center experience 149
Correction to: Impact of COVID-19 on patient–doctor interaction in a complex radiation therapy facility (Supportive Care in Cancer, (2021), 29, 6, (2931-2937), 10.1007/s00520-020-05793-3) 147
May Different Treatment Volumes and Technical Approaches Have an Impact on Second Malignancies Risk? 146
Tumor-associated macrophages (TAMs) modulate response to HER2-targeted agents in a humanized mouse model of breast cancer 140
Recent Advances and Current Challenges in Stereotactic Body Radiotherapy for Ultra-Central Lung Tumors 137
The use of psychological supportive care services and psychotropic drugs in patients with early-stage breast cancer: a comparison between two institutions on two continents 136
Killing two birds with a stone: how to maximise benefit from metastasis-directed therapy and modern systemic treatment in oligometastatic hormone sensitive prostate cancer 126
Stereotactic reirradiation with CyberknifeR for locally recurrent prostate cancer, long-term toxicity and clinical outcomes from a monocentric cohort 122
Radiomic Analysis for Human Papillomavirus Assessment in Oropharyngeal Carcinoma: Lessons and Pitfalls for the Next Future 106
Cardioprotection in patients with anthracycline-treated breast cancer: final analysis from the 2 × 2 randomized, placebo-controlled, double-blind SAFE trial 106
Oncological outcomes after tailored PSMA-PET-guided treatment in biochemical relapse after prostatectomy (PSICHE Trial-NCT 05022914) 77
null 57
Significant interruptions in radiotherapy during curative treatment for prostate cancer are correlated with poorer oncological outcomes 56
Impact of BRCA in patients undergoing abiraterone ± stereotactic body radiotherapy: the ARTO trial 37
Italian adaptation of the European guidelines for breast cancer diagnosis, staging, and preoperative planning: a GRADE-ADOLOPMENT approach 34
The role of stereotactic ablative body radiotherapy in renal cell carcinoma: focus on oligometastatic and oligoprogressive disease 27
Totale 14.713
Salva come PNG Salva come JPEG
Categoria #
all - tutte 44.826
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 44.826
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022328 0 0 0 32 16 20 12 37 17 19 65 110
2022/20231.200 77 229 65 49 99 212 143 84 177 6 32 27
2023/2024681 23 52 71 32 37 99 38 178 9 35 73 34
2024/20254.179 121 350 215 636 1.140 512 68 279 231 147 185 295
2025/20265.256 583 659 525 406 593 172 651 245 326 349 225 522
2026/20271.087 173 311 332 271 0 0 0 0 0 0 0 0
Totale 14.713